Anti-aids Drug

Almost three in five people infected with HIV, or 21.7 million globally, took antiretroviral therapy in 2017, a new record for anti-AIDS drug access, the UN's HIV/AIDS agency said Wednesday.

The life expectancy of HIV-infected people in Europe and the United States has been boosted by a decade since anti-AIDS drugs became available in the mid-1990s, researchers said Thursday.

South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day.

Drug firm Aurobindo Pharma today said it has received tentative approval from the US health regulator to manufacture and market its anti-AIDS combination drug Efavirenz/Emtricitabine and Tenofovir Disoproxil Fumarate tablets in the American market.

Oct. 27th,2000 (PTI) - China was the third country after the United States and Spain to produce the anti-AIDS drug Stavudine. It has now developed a cheaper version of the same drug which will cost two-thirds the US market price of the drug. A Chinese news agency reported that a lot of companies had already placed huge orders for the drug. The dru...

Almost three in five people infected with HIV, or 21.7 million globally, took antiretroviral therapy in 2017, a new record for anti-AIDS drug access, the UN's HIV/AIDS agency said Wednesday.

The life expectancy of HIV-infected people in Europe and the United States has been boosted by a decade since anti-AIDS drugs became available in the mid-1990s, researchers said Thursday.

South Africa's health minister on Monday launched a new single dose anti-AIDs drug which will simplify the world's biggest HIV treatment regime to just one life-saving pill a day.

Drug firm Aurobindo Pharma today said it has received tentative approval from the US health regulator to manufacture and market its anti-AIDS combination drug Efavirenz/Emtricitabine and Tenofovir Disoproxil Fumarate tablets in the American market.

Oct. 27th,2000 (PTI) - China was the third country after the United States and Spain to produce the anti-AIDS drug Stavudine. It has now developed a cheaper version of the same drug which will cost two-thirds the US market price of the drug. A Chinese news agency reported that a lot of companies had already placed huge orders for the drug. The dru...